EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stimulant Medications and Bone Health

Christine M Swanson, Julie H Wolfe, Chadi A Calarge

Current Osteoporosis Reports · 14.05.2026 · 24 (1)

DOI: 10.1007/s11914-026-00965-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Osteoporosis Reports, online erschienen am 14.05.2026. Verfasst von Christine M Swanson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz, 12801 E. 17th Ave. Mail Stop 8106, Aurora, CO, 80045, USA. Chris…. Hauptthemen laut MEDLINE: Central Nervous System Stimulants, Methylphenidate. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of Review This review summarizes the potential impact of stimulant medications on bone health, to raise awareness and optimize their safe use. Recent Findings Stimulant medications can impair bone health through inadequate nutrient/calorie intake and stimulation of the sympathetic nervous system, which regulates bone metabolism. However, their use decreases fracture risk in younger populations ( $$\:\le\:$$ 25 years old) with attention deficit/hyperactivity disorder (ADHD), likely through reductions in impulsivity and injury. Special care may be needed when fractures occur while using these medications, as recent data suggest psychostimulants are associated with impaired fracture healing. Summary Prescription and non-prescription use of psychostimulants have increased. Their ultimate effect on bone health may be a balance between effective behavioral modification and adverse effects on bone metabolism related to nutrition and sympathetic activation. Future research should investigate how psychostimulants affect acquisition of peak bone mass, stability of bone mineral density (BMD) when used through mid/late-life, and fracture healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System StimulantsMethylphenidateBone DensityAttention Deficit Disorder with HyperactivityFractures, BoneFracture HealingBone and BonesHumansNorepinephrineAnimalsDopamine

Stichwörter der Autor:innen

AmphetamineAttention deficit/hyperactivity disorder (ADHD)Bone mineral density (BMD)FractureMethylphenidateStimulant medication

Substanzen

Central Nervous System StimulantsMethylphenidateNorepinephrineDopamine

Autor:innen und Institutionen

  • Division of Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz, 12801 E. 17th Ave. Mail Stop 8106, Aurora, CO, 80045, USA. Christine.Swanson@CUAnschutz.edu.
  • Geriatric Research, Education and Clinical Center, Rocky Mountain Regional VA, Aurora, CO, USA. Christine.Swanson@CUAnschutz.edu.
  • Department of Psychiatry, University of Colorado Anschutz, Aurora, CO, USA. Julie.Wolfe@CUAnschutz.edu.
  • Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA. Chadi.Calarge@bcm.edu.

Förderung

  • NHLBI NIH HHS
  • National Institute of Child Health and Human Development
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Swanson, C. M., Wolfe, J. H., & Calarge, C. A. (2026). Stimulant Medications and Bone Health. Current Osteoporosis Reports, 24(1). https://doi.org/10.1007/s11914-026-00965-2

Vancouver

Swanson CM, Wolfe JH, Calarge CA. Stimulant Medications and Bone Health. Current Osteoporosis Reports. 2026;24(1). doi:10.1007/s11914-026-00965-2

BibTeX
@article{Swanson2026,
  author = {Swanson, Christine M and Wolfe, Julie H and Calarge, Chadi A},
  title = {Stimulant Medications and Bone Health},
  journal = {Current Osteoporosis Reports},
  year = {2026},
  volume = {24},
  number = {1},
  doi = {10.1007/s11914-026-00965-2}
}
Kostenlos starten →